Coherus Oncology, Inc.
CHRS
$0.7472
-$0.0204-2.66%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -130.94M | 28.51M | -450.00K | -29.34M | -59.29M |
| Total Depreciation and Amortization | 4.82M | 5.28M | 5.31M | 4.66M | 4.35M |
| Total Amortization of Deferred Charges | 4.16M | 4.16M | 2.41M | 2.41M | 2.41M |
| Total Other Non-Cash Items | 44.33M | -114.28M | -76.97M | -73.63M | -61.53M |
| Change in Net Operating Assets | 78.13M | 55.89M | 7.73M | 41.64M | -38.86M |
| Cash from Operations | 500.00K | -20.44M | -61.99M | -54.27M | -152.92M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | 0.00 | 7.00M | 7.00M |
| Divestitures | 40.00M | 40.00M | 40.00M | 40.00M | -- |
| Other Investing Activities | -29.93M | 190.32M | 226.07M | 269.17M | 322.88M |
| Cash from Investing | 10.07M | 230.32M | 266.07M | 316.17M | 329.88M |
| Total Debt Issued | 36.98M | 36.98M | 36.98M | 37.12M | -- |
| Total Debt Repaid | -260.39M | -260.39M | -260.39M | -260.39M | -- |
| Issuance of Common Stock | 874.00K | 2.38M | 3.03M | 14.52M | 68.79M |
| Repurchase of Common Stock | -2.00M | -2.48M | -2.79M | -2.96M | -1.55M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 36.40M | 36.53M | 36.33M | 36.14M | -556.00K |
| Cash from Financing | -188.13M | -186.97M | -186.84M | -175.57M | 66.68M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -177.55M | 22.91M | 17.24M | 86.33M | 243.64M |